NOVA MSC BERHAD 19 September 2024 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 636,100 Issue price per share ($$) Malaysian Ringgit (MYR) 0.0400 Par Value($$)…
18 Sep 2024 – Tucked away in central Bali, a distance away from the popular tourist hot-spots is Tabanan – capital town of the regency with the same name. This is exact location of where Kasih Ibu Hospital (KIH) chose to site their 4th hospital to serve a regency with a population of half a million. Over the weekend, KIH…
NOVA MSC BERHAD 10 September 2024 Type of Meeting General Indicator Outcome of Meeting Date of Meeting 10 Sep 2024 Time 03:00 PM Venue(s) A fully virtual basis via online meeting platform of Vote2U e-Portal at https://web.vote2u.my (Domain Registration No. with MyNIC: D6A471702) provided by Agmo Digital Solutions Sdn. Bhd. Malaysia Outcome of Meeting On behalf of…
9 Sep 2024 – Nova MSC is pleased to share that its subsidiary EyRIS has secured an award to rollout SELENA+ as part of the National Diabetic Retinopathy (DR) Screening Program in Brunei Darussalam. Brunei Darussalam is one of the earliest countries in the world to strengthen its public health system by integrating a deep learning system into their national…
NOVA MSC BERHAD 09 September 2024 Type Announcement Subject OTHERS Description NOVA MSC BERHAD (NOVAMSC OR THE COMPANY) EYRIS Pte Ltd, a subsidiary of NOVAMSC, secures RM7.13 million project order in Brunei Darussalam The Board of Directors of the Company is pleased to announce that its subsidiary, EYRIS Pte Ltd (“EYRIS”), has received an order from JPMCnova Sdn…
NOVA MSC BERHAD 06 September 2024 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 13,760,000 Issue price per share ($$) Malaysian Ringgit (MYR) 0.0400 Par Value($$) (if…
NOVA MSC BERHAD 29 August 2024 Financial Year End 31 Mar 2025 Quarter 1 Qtr Quarterly report for the financial period ended 30 Jun 2024 The figures have not been audited NMSC_report_FY2425_1Qtr.pdf
26 Aug 2024 – EyRIS is thrilled to announce our strategic partnership with @i-Cognitio Sciences (i-cog), a pioneering Hong Kong-based company, to integrate their cutting-edge RetinAD technology into our EySCAN platform. This collaboration represents a major leap forward in non-invasive brain health assessments and early detection of Alzheimer’s risk. RetinAD is an AI-powered tool that analyzes retinal images to deliver…
NOVA MSC BERHAD 19 August 2024 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 964,700 Issue price per share ($$) Malaysian Ringgit (MYR) 0.0400 Par Value($$)…
NOVA MSC BERHAD 12 August 2024 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal ESOS Details of corporate proposal Ten (10) years Employee’ Share Option Scheme of up thirty percent (30%) of the issued paid-up share capital of the Company No. of shares issued under this corporate proposal 800,000…
8 Aug 2024 – Today, EyRIS had the pleasure of hosting 10 medical students and 2 lecturers from Tsinghua Medicine 清华大学医学院 who were in Singapore as part of their study tour. The stop-over at EyRIS was to provide budding doctors an insight to Singapore’s healthcare start-up eco-system; from clinical research, regulatory hurdles and translational journey. Our team led by Dr…
NOVA MSC BERHAD 31 July 2024 Type Announcement Subject OTHERS Description Nova MSC Berhad (NOVAMSC or Company) Signing of Share Subscription Agreements in Dex-lab and Eyris Reference is made to the Company’s announcements dated 19 April 2024 in relation to the Term Sheets with Jostar VCC (“Jostar”), and the Company’s announcements dated 10 May 2024 in relation to the…